5.43
price up icon1.31%   0.07
after-market Dopo l'orario di chiusura: 5.43
loading
Precedente Chiudi:
$5.36
Aprire:
$5.36
Volume 24 ore:
297.42K
Relative Volume:
0.63
Capitalizzazione di mercato:
$322.24M
Reddito:
-
Utile/perdita netta:
$-72.89M
Rapporto P/E:
-2.2438
EPS:
-2.42
Flusso di cassa netto:
$-68.47M
1 W Prestazione:
-5.73%
1M Prestazione:
+14.08%
6M Prestazione:
-39.26%
1 anno Prestazione:
-41.30%
Intervallo 1D:
Value
$5.26
$5.71
Intervallo di 1 settimana:
Value
$5.25
$5.79
Portata 52W:
Value
$3.555
$12.92

Astria Therapeutics Inc Stock (ATXS) Company Profile

Name
Nome
Astria Therapeutics Inc
Name
Telefono
617-349-1971
Name
Indirizzo
22 BOSTON WHARF ROAD, BOSTON
Name
Dipendente
78
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
ATXS's Discussions on Twitter

Confronta ATXS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ATXS
Astria Therapeutics Inc
5.43 322.24M 0 -72.89M -68.47M -2.42
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Astria Therapeutics Inc Stock (ATXS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-29 Iniziato Cantor Fitzgerald Overweight
2025-01-31 Iniziato JMP Securities Mkt Outperform
2024-07-29 Iniziato TD Cowen Buy
2023-03-28 Iniziato Evercore ISI Outperform

Astria Therapeutics Inc Borsa (ATXS) Ultime notizie

pulisher
Jun 18, 2025

(ATXS) Trading Report - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 18, 2025

Astria Therapeutics to Participate in Upcoming Oppenheimer Innovators in Immunology & Inflammation Summit - BioSpace

Jun 18, 2025
pulisher
Jun 18, 2025

Astria Therapeutics to Participate in Upcoming Oppenheimer Innov - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Astria CEO Discusses Breakthrough Dermatology Treatments at Major Oppenheimer Summit - Stock Titan

Jun 18, 2025
pulisher
Jun 15, 2025

HC Wainwright Reaffirms “Buy” Rating for Astria Therapeutics (NASDAQ:ATXS) - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Target Price at $30.00 - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Astria Therapeutics (ATXS) Receives Reiterated Buy Rating and $1 - GuruFocus

Jun 14, 2025
pulisher
Jun 13, 2025

Astria Therapeutics (ATXS) Reports Promising Results for Navenib - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Astria Therapeutics Announces Positive Initial Results from the - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Astria Therapeutics Says New Data Back Navenibart Dose Regimen for Hereditary Angioedema - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Astria Therapeutics Announces Positive Initial Results from the ALPHA-SOLAR Long-Term Open-Label Trial of Navenibart in Hereditary Angioedema Patients at the European Academy of Allergy and Clinical Immunology Annual Congress - Yahoo Finance

Jun 13, 2025
pulisher
Jun 13, 2025

California State Teachers Retirement System Increases Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Sells 2,042 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Astria Therapeutics Stockholders Approve Key Amendments - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Astria Therapeutics, Inc. (NASDAQ:ATXS) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Estimates ATXS FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress - BioSpace

Jun 09, 2025
pulisher
Jun 06, 2025

(ATXS) Investment Report - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Astria Therapeutics to Present at Upcoming European Academy of A - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress | ATXS Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 05, 2025

Jane Street Group LLC Has $233,000 Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Acquires Shares of 5,572 Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Lis - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ATXS Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

ProShare Advisors LLC Invests $140,000 in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Jun 03, 2025
pulisher
May 31, 2025

Deutsche Bank AG Buys 13,986 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

May 31, 2025
pulisher
May 29, 2025

Citizens JMP maintains $25 target on Astria Therapeutics stock By Investing.com - Investing.com Canada

May 29, 2025
pulisher
May 28, 2025

Astria Therapeutics to Present at Upcoming Jefferies Global Healthcare Conference - Business Wire

May 28, 2025
pulisher
May 26, 2025

Janus Henderson Group PLC Takes Position in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

May 26, 2025
pulisher
May 23, 2025

Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficien - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema Workshop | ATXS Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema Workshop - Business Wire

May 23, 2025
pulisher
May 23, 2025

Northern Trust Corp Has $4.10 Million Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

May 23, 2025
pulisher
May 22, 2025

Astria Therapeutics to Present at Upcoming Eastern Allergy Confe - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference | ATXS Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

New Clinical Data: Astria's Navenibart Cuts Hereditary Angioedema Attack Severity, Reduces Rescue Med Usage - Stock Titan

May 22, 2025
pulisher
May 22, 2025

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference - New Castle News

May 22, 2025
pulisher
May 21, 2025

Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Price Target at $30.00 - Defense World

May 21, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Buys 2,878 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

May 18, 2025
pulisher
May 18, 2025

Cantor Fitzgerald Analysts Lower Earnings Estimates for ATXS - Defense World

May 18, 2025
pulisher
May 17, 2025

Wedbush Lowers Earnings Estimates for Astria Therapeutics - Defense World

May 17, 2025
pulisher
May 17, 2025

Q2 EPS Estimate for Astria Therapeutics Lowered by Analyst - Defense World

May 17, 2025
pulisher
May 17, 2025

Astria Therapeutics’ (ATXS) “Overweight” Rating Reiterated at Cantor Fitzgerald - Defense World

May 17, 2025
pulisher
May 16, 2025

FMR LLC Reduces Holdings in Astria Therapeutics Inc - GuruFocus

May 16, 2025
pulisher
May 16, 2025

(ATXS) Technical Data - news.stocktradersdaily.com

May 16, 2025
pulisher
May 16, 2025

Astria Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025
pulisher
May 15, 2025

Analysts Offer Insights on Healthcare Companies: Astria Therapeutics (ATXS), Aquestive Therapeutics (AQST) and Olema Pharmaceuticals (OLMA) - The Globe and Mail

May 15, 2025
pulisher
May 15, 2025

Astria Therapeutics Reports Increased Loss Amid Rising R&D Costs - TipRanks

May 15, 2025
pulisher
May 14, 2025

Analyst Reiterates Overweight Rating for ATXS with Stable Price Target | ATXS Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Here's Why We're Not Too Worried About Astria Therapeutics' (NASDAQ:ATXS) Cash Burn Situation - Yahoo Finance

May 14, 2025

Astria Therapeutics Inc Azioni (ATXS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):